Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2003
10/09/2003WO2003082923A1 Process for crosslinking polypeptides
10/09/2003WO2003082913A1 Genes from drought stress tolerant tea plant and a method of introducing water-stress tolerance
10/09/2003WO2003082903A2 Hybrid phosphoinositide phospholipids: compositions and uses
10/09/2003WO2003082901A2 Template-driven processes for synthesizing polymers and components related to such processes
10/09/2003WO2003082425A2 System, method and apparatus for the rapid detection and analysis of airborne biological agents
10/09/2003WO2003082342A1 Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082266A1 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
10/09/2003WO2003082255A2 Use of mob-5 in pain
10/09/2003WO2003082216A2 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003WO2003082214A2 Human metabolic models and methods
10/09/2003WO2003082210A2 Targets, methods, and reagents for diagnosis and treatment of schizophrenia
10/09/2003WO2003082202A2 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/09/2003WO2003082189A2 Method for producing pseudo islets
10/09/2003WO2003082079A2 Diagnostics for the detection of acidovorax avenae subsp. citrulli, causal agent of bacterial fruit blotch in melons
10/09/2003WO2003082078A2 Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles
10/09/2003WO2003082072A2 Methods for selecting treatment regimens and predicting outcomes in cancer patients
10/09/2003WO2003060463A3 Methods of screening, determining, developing, and utilizing negative cross resistance toxins
10/09/2003WO2003054511A3 Methods for quantitating nucleic acids using coupled ligation and amplification
10/09/2003WO2003052132A3 Linear and hairpin oligonucleotide analogues comprising intercalator pseudonucleotides
10/09/2003WO2003052115A3 Post-synthesis labeling of nucleic acids and uses thereof
10/09/2003WO2003040303A3 Functional assay for agonist activation of receptors
10/09/2003WO2003039234A3 Pharmacogenomics-based system for clinical applications
10/09/2003WO2003038442A3 Processes for producing optimized pharmacophores
10/09/2003WO2003037367A3 New bacterium causing poultry disease and vaccine derived thereof
10/09/2003WO2003036280A3 Electro thermometric method and apparatus
10/09/2003WO2003035048A3 Methods for the treatment of osteoarthritis and compositions thereof
10/09/2003WO2003032923A3 Induction of beta cell differentiation in human cells
10/09/2003WO2003031933A3 Materials and methods for detection of pathogenic guignardia citricarpa
10/09/2003WO2003031054A3 Arrays having clustered arrangements and methods of making and using them
10/09/2003WO2003030725A3 Pancreatic cancer diagnosis and therapies
10/09/2003WO2003029828A3 Screening method for different indications using bnpi and/or dnpi
10/09/2003WO2003029421A3 Regulated breast cancer genes
10/09/2003WO2003026493A3 Diagnosis and treatment of diseases caused by mutations in cd72
10/09/2003WO2003023051A3 Lateral flow test format for enzyme assays
10/09/2003WO2003020928A3 Identification of eukaryotic internal ribosome entry site (ires) elements
10/09/2003WO2003016528A3 Oligonucleotide compositions and their use to induce apoptosis
10/09/2003WO2003014149A3 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
10/09/2003WO2003013534A3 Methods for the treatment of cancer with irinotecan based on cyp3a5
10/09/2003WO2003013533A3 Methods for improved treatment of cancer with irinotecan based on mrp1
10/09/2003WO2003013224A3 Herbicide tolerant cotton plants and methods for producing and identifying same
10/09/2003WO2003012134A3 Paget disease of bone
10/09/2003WO2003012133A3 Isp-1 and ctb-1 genes and uses thereof
10/09/2003WO2003012131A3 Assays for protease inhibitors, methods and means
10/09/2003WO2003011119A3 Methods and compositions for diagnosis and treatment of vascular conditions
10/09/2003WO2003003015A3 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof
10/09/2003WO2003002760A3 Method for detecting cytosine methylation by comparatively analysing single strands of amplificates
10/09/2003WO2003000926A3 Method for high sensitivity detection of cytosine-methylation
10/09/2003WO2002102828A3 Chimeric flavivirus vectors
10/09/2003WO2002101353A3 Methods and products for analyzing nucleic acids based on methylation status
10/09/2003WO2002097129A3 Methods for sorting cells
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002095000A3 Molecular toxicology modeling
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002090934A3 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
10/09/2003WO2002088383A3 Method and system for identifying targets by nucleocytoplasmic cycling and use thereof
10/09/2003WO2002083939A3 Controllable increase in the sensitivity of hybridisation detection
10/09/2003WO2002083936A3 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/09/2003WO2002083929A3 System and method for quantitating transcription factors
10/09/2003WO2002079505A3 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci
10/09/2003WO2002076286A3 Prognostic methods for breast cancer
10/09/2003WO2002072877A3 Method for the detection of dna sequence variations
10/09/2003WO2002070746A3 Methods for global profiling gene regulatory element activity
10/09/2003WO2002070744A3 Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds
10/09/2003WO2002060318A3 Detection of methylated cpg rich sequences diagnostic for malignant cells
10/09/2003WO2002059381A3 Gene for identifying individuals with familial dysautonomia
10/09/2003WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
10/09/2003WO2002057491A3 Direct multiplex characterization of genomic dna
10/09/2003WO2002057484A3 Method and test system for identifying substances which protect nerve cells
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002038797A3 Modulators of bruton's tyrosine kinase, their identification and use
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002031188A3 Method and device for predicting haplotypes
10/09/2003WO2002031160A3 Regulation of human phospholipase a2-like enzyme
10/09/2003WO2002027027A8 Method of screening for therapeutics for infectious diseases
10/09/2003WO2002022854A3 Method for the detection and measurement of biomass
10/09/2003WO2002022664A3 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
10/09/2003WO2002021418A3 Method and system for identifying commercially distributed organisms
10/09/2003WO2002020851A9 Haplotypes of the scya24 gene
10/09/2003WO2002020835A3 Genetic study
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002016636A3 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders
10/09/2003WO2002014545A3 Method for determining weather a test compound binds to a large rna target
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2002010382A3 Trp8, trp9 and trp10, markers for cancer
10/09/2003WO2002008460A3 Methods for detection of human papillomavirus mrna
10/09/2003WO2002008459A3 Method for detecting micro-organisms
10/09/2003WO2001071027A3 mRNA AMPLIFICATION
10/09/2003US20030192074 Encoding an MLA polypeptide which is capable of recognising and activating a race specific defense response in a plant into which the nucleic acid is introduced and expressed, in response to challange with a congnate Erysiphe graminis
10/09/2003US20030192071 Isolated and purified nucleic acids comprising a gene and a regulatory region for the gene expression of the same
10/09/2003US20030192065 Human nerve growth factor exon 1 and exon 3 promoters
10/09/2003US20030191297 Avian ghd genes and their use in methods for sex identification in birds
10/09/2003US20030191146 Oxidoreductase inhibitors; bacteriostats, bactericides
10/09/2003US20030191114 Binding to ligand; induce signals
10/09/2003US20030191084 High affinity nucleic acid ligands of complement system proteins
10/09/2003US20030191083 Screening, detection microbiocides; sepsis, rheumatic diseases, antiarthritic agents; bactericides
10/09/2003US20030191079 Methods for treating and preventing infectious disease
10/09/2003US20030191078 Prevent reproduction of oligonucleotides
10/09/2003US20030191074 Antibody therapy; immobilization
10/09/2003US20030191073 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
1 ... 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 ... 3003